Core One Labs 관리

관리 기준 확인 2/4

Core One Labs CEO는 Joe Shacker, Jul2020 에 임명되었습니다 의 임기는 4.33 년입니다. 는 € 27.07K 가치에 해당하는 회사 주식의 0.6% 직접 소유합니다. 27.07K. 경영진과 이사회의 평균 재임 기간은 각각 3.9 년과 3.6 년입니다.

주요 정보

Joe Shacker

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	4.3yrs
CEO 소유권	0.6%
경영진 평균 재임 기간	3.9yrs
이사회 평균 재임 기간	3.6yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Joe Shacker 의 보수는 Core One Labs 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2023	n/a	n/a	-CA$16m
Dec 31 2022	n/a	n/a	-CA$16m
Sep 30 2022	n/a	n/a	-CA$15m
Jun 30 2022	n/a	n/a	-CA$19m
Mar 31 2022	n/a	n/a	-CA$25m
Dec 31 2021	CA$243k	CA$120k	-CA$37m
Sep 30 2021	n/a	n/a	-CA$59m
Jun 30 2021	n/a	n/a	-CA$77m
Mar 31 2021	n/a	n/a	-CA$70m
Dec 31 2020	CA$60k	CA$60k	-CA$47m

보상 대 시장: German 시장에서 비슷한 규모의 회사에 비해 Joe 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Joe 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Joe Shacker (33 yo)

4.3yrs

테뉴어

CA$242,751

보상

Mr. Joel Shacker also known as Joe, is Chief Executive Officer at Core One Labs Inc since July 3, 2020 and has been its Director since May 29, 2020. Mr. Shacker serves as Director at American Future Fuel C...

리더십 팀

이름	위치	테뉴어	보상	소유권
Joel Shacker	CEO & Director	4.3yrs	CA$242.75k	0.60% € 27.1k
Geoffrey Balderson	CFO, Secretary & Director	4.3yrs	CA$40.92k	0.079% € 3.5k
Santiago Ferro	Chief Medical Officer & Director	3.5yrs	CA$100.00k	0.89% € 40.0k
Brad Eckenweiler	Founder & Advisor	no data	데이터 없음	데이터 없음
Jan Burian	Chief Technical Officer	no data	데이터 없음	데이터 없음
Elizabeth Matthews	Head of Scientific & Regulatory Affairs	3.6yrs	데이터 없음	데이터 없음

3.9yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 관리: LD6 의 관리팀은 경험 ( 3.9 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Joel Shacker	CEO & Director	4.5yrs	CA$242.75k	0.60% € 27.1k
Geoffrey Balderson	CFO, Secretary & Director	3.3yrs	CA$40.92k	0.079% € 3.5k
Santiago Ferro	Chief Medical Officer & Director	1.8yrs	CA$100.00k	0.89% € 40.0k
Patrick Morris	Independent Director	4.8yrs	데이터 없음	0.17% € 7.5k
Dan Polonenko	Member of Advisory Board	3.6yrs	데이터 없음	데이터 없음

3.6yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 이사회: LD6 의 이사회는 경험(평균 재직 기간 3.6 년)으로 간주됩니다.

Core One Labs 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Core One Labs Inc. Announces Management Changes

Core One Labs Inc., Annual General Meeting, Feb 08, 2023

Less than half of directors are independent

Core One Labs Inc. Announces Resignation of Ryan Hoggan from its Board of Directors

Less than half of directors are independent

Executive Chairman recently sold €55k worth of stock

Recent updates

New major risk - Financial data availability

Core One Labs Inc. announced that it expects to receive CAD 1.5 million in funding

New minor risk - Financial data availability

Core One Labs' Akome Reveals Impressive Results for Its Psychedelic Bio- Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

New major risk - Market cap size

New major risk - Shareholder dilution

Core One Labs Inc. announced that it has received CAD 0.2 million in funding

Core One Labs Inc. announced that it has received CAD 0.2 million in funding

Core One Labs Inc. announced that it expects to receive CAD 1 million in funding

Core One Labs Inc. announced that it expects to receive CAD 1 million in funding

Core One's Akome Reveals Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's Disease

Full year 2023 earnings released: CA$0.49 loss per share (vs CA$1.40 loss in FY 2022)

Core One Labs Inc.'s Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease

Core One Labs Inc. Announces Management Changes

Core One Labs Inc. (CNSX:COOL) acquired GMP Drug Inc. for CAD 3.5 million.

Core One Labs Inc., Annual General Meeting, Feb 08, 2023

Core One Labs Inc. Prepares for Commercial Production of API-Grade Psilocybin

Less than half of directors are independent

Core One Labs Applauds New Study Supporting Psilocybin Psychedelic Drug Therapy May Help Treat Alcohol Addiction

Core One Labs Inc. Announces Resignation of Ryan Hoggan from its Board of Directors

Less than half of directors are independent

Core One Labs Inc. (CNSX:COOL) acquired Awakened Biosciences Inc.

Core One Labs Inc. Expects Imminent Breakthrough to Produce NMT, Precursor to DMT

Core One Labs Applauds Health Canada’s Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments

Core One Labs Inc. (CNSX:COOL) acquired New Path Laboratories Inc. for CAD 3.4 million.

Core One Labs Inc. (CNSX:COOL) acquired Frontier Mycology Corp. for CAD 7.5 million.

Executive Chairman recently sold €55k worth of stock

Chief Science Officer & Director John Sanderson has left the company

Core One Labs Inc. (CNSX:COOL) completed the acquisition of Akome Biotech Ltd.

Core One Labs Inc. (CNSX:COOL) acquired Bluejay Mental Health Group Inc.

Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy

Core One Labs Inc. and Vocan Biotechnologies Inc. Initiates First Strain Production for Biosynthetic Psilocybin

Executive Chairman recently sold €65k worth of stock

Core One Labs Inc. (CNSX:COOL) entered into a letter of intent to acquire Ketamine Infusion Centers of Texas, LLC for $0.2 million.

High Tower Capital, Inc. completed the acquisition of Certain Assets of Core One Labs Inc. (CNSX : COOL).

Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to Its Patented Thinstrip Delivery Method

Core One Labs Inc. Announces Board Changes

Core One Labs Inc. (CNSX:COOL) completed the acquisition of Vocan Biotechnologies Inc.

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령